These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33272650)

  • 1. Long-Term Outcome of ABO-Incompatible Kidney Transplantation in Patients Treated With Low-Dose Rituximab Regimen.
    Sasaki H; Hotta K; Mitsuke A; Fukasawa Y; Tanabe T; Higuchi H; Takada Y; Harada H
    Transplant Proc; 2021 Apr; 53(3):989-994. PubMed ID: 33272650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation.
    Takahashi K; Saito K; Takahara S; Fuchinoue S; Yagisawa T; Aikawa A; Watarai Y; Yoshimura N; Tanabe K; Morozumi K; Shimazu M;
    Clin Exp Nephrol; 2017 Aug; 21(4):705-713. PubMed ID: 27534951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percentage of CD19
    Hirose T; Iwami D; Hotta K; Sasaki H; Higuchi H; Shinohara N
    Transplant Proc; 2019 Jun; 51(5):1382-1386. PubMed ID: 31027828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABO-incompatible pediatric kidney transplantation without antibody removal.
    Kawamura T; Hamasaki Y; Takahashi Y; Hashimoto J; Kubota M; Muramatu M; Itabashi Y; Hyodo Y; Ohashi Y; Aikawa A; Sakai K; Shishido S
    Pediatr Nephrol; 2020 Jan; 35(1):95-102. PubMed ID: 31673829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological Analysis in ABO-Compatible and ABO-Incompatible Kidney Transplantation by Performance of 3- and 12-Month Protocol Biopsies.
    Masutani K; Tsuchimoto A; Kurihara K; Okabe Y; Kitada H; Okumi M; Tanabe K; Nakamura M; Kitazono T; Tsuruya K;
    Transplantation; 2017 Jun; 101(6):1416-1422. PubMed ID: 27391195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological and Extended Clinical Outcomes After ABO-Incompatible Renal Transplantation Without Splenectomy or Rituximab.
    Chow KV; Flint SM; Shen A; Landgren A; Finlay M; Murugasu A; Masterson R; Hughes P; Cohney SJ
    Transplantation; 2017 Jun; 101(6):1433-1440. PubMed ID: 27495772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Steroid Withdrawal Protocol With Basiliximab and Rituximab in ABO-Incompatible Kidney Transplant Recipients.
    Tojimbara T; Yashima J; Shirai H; Yamazaki T; Koyama I; Nakajima I
    Transplant Proc; 2020; 52(6):1705-1708. PubMed ID: 32444132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of blood group antibodies in ABO-incompatible living-donor kidney transplantation.
    Sugiyama K; Hyodo Y; Aikawa A
    Int J Urol; 2015 Oct; 22(10):931-6. PubMed ID: 26108258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualized Preconditioning for ABO-Incompatible Living-Donor Kidney Transplantation: An Initial Report of 48 Cases from China.
    Wang XD; Liu JP; Fan Y; Song TR; Shi YY; Li YM; Lv YH; Li XH; Huang ZL; Lin T
    Ann Transplant; 2020 Feb; 25():e920224. PubMed ID: 32029699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between response to rituximab and antibody-mediated rejection in ABO-incompatible living kidney transplantation.
    Maenosono R; Unagami K; Kakuta Y; Furusawa M; Okumi M; Azuma H; Ishida H; Tanabe K
    Int J Urol; 2019 Dec; 26(12):1114-1120. PubMed ID: 31522467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single fixed low-dose rituximab as induction therapy suppresses de novo donor-specific anti-HLA antibody production in ABO compatible living kidney transplant recipients.
    Tomita Y; Iwadoh K; Ogawa Y; Miki K; Kato Y; Kai K; Sannomiya A; Koyama I; Kitajima K; Nakajima I; Fuchinoue S
    PLoS One; 2019; 14(10):e0224203. PubMed ID: 31644555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Outcomes of ABO-incompatible Pediatric Living Donor Liver Transplantation.
    Honda M; Sugawara Y; Kadohisa M; Shimata K; Sakisaka M; Yoshii D; Uto K; Hayashida S; Ohya Y; Yamamoto H; Yamamoto H; Inomata Y; Hibi T
    Transplantation; 2018 Oct; 102(10):1702-1709. PubMed ID: 29620615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of 2 Doses of Rituximab on B-Cell and Antidonor Antibody and Outcomes of ABO-Incompatible Living-Donor Pediatric Kidney Transplant.
    Hamasaki Y; Aikawa A; Itabashi Y; Muramatsu M; Hyoudou Y; Shinoda K; Takahashi Y; Sakurabayashi K; Mizutani T; Oguchi H; Kawamura T; Sakai K; Shishido S
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):105-109. PubMed ID: 30777532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal dose of rituximab in ABO-incompatible kidney transplantation in patients with low anti-A/B antibody titers: A single-center retrospective cohort study.
    Okada M; Narumi S; Hasegawa Y; Futamura K; Hiramitsu T; Ichimori T; Goto N; Kobayashi T; Uchida K; Takeda A; Watarai Y
    Clin Transplant; 2023 Feb; 37(2):e14915. PubMed ID: 36634703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens.
    Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T
    Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The low dose of rituximab in ABO-incompatible kidney transplantation without a splenectomy: a single-center experience.
    Shirakawa H; Ishida H; Shimizu T; Omoto K; Iida S; Toki D; Tanabe K
    Clin Transplant; 2011; 25(6):878-84. PubMed ID: 21175849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of ABO Blood Type-Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in Japan.
    Hamano I; Hatakeyama S; Fujita T; Murakami R; Hamaya T; Togashi K; Suzuki Y; Yamamoto H; Yoneyama T; Yoneyama T; Hashimoto Y; Narumi S; Tomita H; Ohyama C
    Transplant Proc; 2020; 52(6):1700-1704. PubMed ID: 32448659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid Withdrawal Using Everolimus in ABO-Incompatible Kidney Transplant Recipients With Post-Transplant Diabetes Mellitus.
    Nanmoku K; Shinzato T; Kubo T; Shimizu T; Kimura T; Yagisawa T
    Transplant Proc; 2018 May; 50(4):1050-1055. PubMed ID: 29631750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One hundred ABO-incompatible kidney transplantations between 2004 and 2014: a single-centre experience.
    Zschiedrich S; Jänigen B; Dimova D; Neumann A; Seidl M; Hils S; Geyer M; Emmerich F; Kirste G; Drognitz O; Hopt UT; Walz G; Huber TB; Pisarski P; Kramer-Zucker A
    Nephrol Dial Transplant; 2016 Apr; 31(4):663-71. PubMed ID: 26610596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desensitization with the Use of an Antibody Removal-Free Protocol in ABO-Incompatible Kidney Transplant Recipients with a Low Anti-A/B Antibody Titer.
    Nanmoku K; Shinzato T; Kubo T; Shimizu T; Kimura T; Yagisawa T
    Transplant Proc; 2018 May; 50(4):982-986. PubMed ID: 29731097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.